Latest developments in prostate cancer researchtext editorEmerging Infectious Diseases
Rehabilitation is vital in improving the quality of life for patients with cancer, including those with brain tumors. Ongoing research and collaboration are essential to address the unmet needs that still exist in this space and to optimize rehabilitation strategies. To further the discussion of rehab...
ESMO and WCLC: Latest developments in EGFR mutated NSCLC More videos + elearning Urothelial tumours of the urinary tract coding issues Breast cancer coding issues Colorectal cancer coding issues Moreelearning + Journal Nodular basal cell carcinoma of the scrotum: a case report and review of the li...
Compass Oncology provides hope and healing for cancer patients in the Portland-Vancouver areas using the latest cancer treatments and research.
This review delves into recent developments concerning metastasis-associated genes, important signaling pathways, tumor microenvironment, metabolic processes, peripheral immunity, and mechanical forces and cancer metastasis. In addition, we combine recent advances with a particular emphasis on the prospect of...
Twenty years since the launch of Nature Reviews Gastroenterology & Hepatology, developments in research and clinical practice continue apace. In our anniversary issue, we focus on the past, present and future of gastroenterology and hepatology. Editorial25 Oct 2024 Nature Reviews Gastroenterology & Hepat...
IDE397 Shows Early Antitumor Activity, Safety in MTAP-Deletion Urothelial Cancer and NSCLC October 16th 2024 How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD October 23rd 2024 ADCs Redefine HER2+ NSCLC Landscape With Potential to Shift to ...
Over the past year, dozens of research papers and patent applications describing new Cdc25 inhibitors belonging to different structural classes have been disclosed. In this review, we give an overview on the current status in the field of medicinal chemistry of Cdc25B inhibitors. In addition, ...
In our review, we focus mainly on the latest updates from clinical guidelines and novel therapies that have been recently investigated or are under investigation for PDAC. We used PubMed as a search tool for finding original research articles addressing the latest developments in diagnosing and ...
Only papers published in English until March 2024 were reviewed. With some limited exceptions, only papers published over the last three years were considered with the aim of providing a summary as up to date as possible of the most recent developments on the topic. The final reference list ...